No clear answer
Spasticity: improve symptoms or function in MS (type not specified)
MS (type not specified) · Spasticity
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 5
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
No controlled trial has reported a result yet.
Other linked trials: 5
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 5
These linked trials do not set the status.
- OMNI-CanNo result found
Phase 2 · 2018 · Not randomised
- Effects of Vaporized Marijuana on Neuropathic PainNo result found
Phase 1/2 · 2009 · Placebo-controlled
- One Year Extension Study To Protocol C2/5/TZ:MS-05Stopped, other reason
Phase 1/2 · 2008 · Not randomised
- Cannabis for Spasticity in Multiple SclerosisStopped, other reason
Phase 1/2 · 2003 · Not randomised
Phase 1/2 · 2001 · Not randomised
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-28Trials: 42 → 5
- 2026-10-28Status changed from Being tested to No clear answer
- 2026-10-28Trials: 46 → 42
- 2026-10-27First listed as Being tested
Related hypotheses
- Spasticity: improve symptoms or function in relapsing and progressive MS
- Arbaclofen: improve symptoms or function in MS (type not specified)
- Baclofen: improve symptoms or function in MS (type not specified)
- Botulinum toxin type a: improve symptoms or function in MS (type not specified)
- Cannabidiol: improve symptoms or function in MS (type not specified)
- Dronabinol: improve symptoms or function in MS (type not specified)
- Nabilone: improve symptoms or function in MS (type not specified)
- Nabiximols: improve symptoms or function in MS (type not specified)
- Onabotulinumtoxina: improve symptoms or function in MS (type not specified)
- Rimabotulinumtoxinb: improve symptoms or function in MS (type not specified)
- Tizanidine: improve symptoms or function in MS (type not specified)
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error